3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Alternate Names : Dysmenorrhea. Menstrual cramps are the pain and cramping some women experience during their monthly periods. The term dysmenorrhea usually refers to pain and cramps severe enough to prevent normal activity


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > AIDS/HIV -

Orange chemical hailed as a treatment for AIDS

AIDS/HIVSep 27, 05

An Australian pharmaceutical company said on Tuesday a naturally occurring chemical extracted from oranges can be used to treat HIV/AIDS, influenza, SARS and the common cold.

Citrofresh International Ltd. said Europe’s Retroscreen Virology Laboratory had found its Citrofresh bioflavanoid compound to be effective against the HIV-1 virus, the human influenza A virus including Avian influenza or bird flu, the Urbani SARS virus and the human rhinovirus.

It did not say whether the results had been independently verified or whether they would be published.

Shares in the anti-virus treatment developer, with a market value of A$20 million ($15 million), more than tripled to A$0.70, prompting a trading halt in its shares as it prepared more information, expected to be released before the market opens on Thursday.

Bioflavonoids are a group of chemical compounds naturally found in certain fruits, vegetables, teas, wines, nuts, seeds, and roots with anti-oxidant and anti-inflammatory properties. However, they are usually derived from citrus fruit rinds.

“Retroscreen Virology confirmed that Citrofresh exhibits significant (viricidal) activity against all four viruses tested,” the company said in a statement to the Australian Stock Exchange.

Citrofresh, which sells anti-bacterial products for the food industry, provided no details of the results of tests it commissioned from Retroscreen Virology.

Shares in Citrofresh, which could not be reached for comment, were off their highs at A$0.535, when the trading halt was imposed, still more than double its A$0.21 close on Monday.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Delay in AIDS drug use in South Africa costly
  Protein identified that turns off HIV-fighting T cells
  Study examines repeated exposure to HIV in treatment-suppressed HIV patients
  Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
  What HIV Needs: Identification of Human Factors May Yield Novel Therapeutic Targets for HIV
  HIV Status Unknown for Most “Negative” Men Online
  A Young Woman’s Battle With HIV
  WHO publishes how-to guide on fighting AIDS
  African ex-leaders to press politicians over AIDS
  Mexicans in U.S. illegally at more risk of AIDS
  Government to release revised U.S. HIV estimates
  U.S. drops trial of one AIDS vaccine

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site